Skip to content

BBOT BRIDGEBIO ONCOLOGY THERAPEUT

Follow

CL A ORD SHS (common), issuer CIK 1869105

0 managers (0 13F filers) reported a position in BBOT shares at 2025-09-30. 0 filers opened a position and 33 filers sold out during the quarter.

Managers
0
13F filers
0
New
0
Added
0
Reduced
0
Sold out
33
Shares held by filers

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

The latest Form 4 transactions, non-derivative.
OwnerDateSharesPriceFiling
Beltran Pedrodirector, officer (President and CEO)2026-11-18-1,870 S$1.841Form 4
Cobo Marcofficer (Principal Accounting Officer)2026-11-13-78 S$2.37Form 4

13F holders, Q3 2025

Filers in the available 13F reports with a share position at 2025-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource

Events

  • Beltran Pedro sold 1,870 BBOT shares on 2026-11-18, Form 4 filed 2026-11-20. 0001193125-26-470272

    Accepted , ingested
  • Cobo Marc sold 78 BBOT shares on 2026-11-13, Form 4 filed 2026-11-17. 0001193125-26-465625

    Accepted , ingested